
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 101.590 | 101.590 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.474 | 19.570 |
Price to Book | 2.704 | 3.777 |
Price to Sales | 1.943 | 2.182 |
Price to Cash Flow | 15.472 | 14.572 |
Dividend Yield | 0.538 | 1.490 |
5 Years Earnings Growth | 12.774 | 9.859 |
Number of long holdings: 34
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UCB | BE0003739530 | 8.39 | 255.70 | +0.95% | |
Swedish Orphan Biovitrum | SE0000872095 | 6.99 | 315.60 | +3.20% | |
Argen-X | NL0010832176 | 6.00 | 728.00 | -0.27% | |
Zealand Pharma | DK0060257814 | 5.16 | 473.20 | +0.68% | |
Fresenius SE | DE0005785604 | 4.97 | 48.1300 | -0.15% | |
H Lundbeck B | DK0061804770 | 3.76 | 45.88 | +0.44% | |
Merus | NL0011606264 | 3.62 | 94.60 | +0.17% | |
Uniphar | IE00BJ5FQX74 | 3.55 | 3.94 | +1.54% | |
Innovent Biologics | KYG4818G1010 | 3.47 | 86.90 | +0.93% | |
Ascendis Pharma AS | US04351P1012 | 3.21 | 200.59 | -2.25% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00BFMFDC02 | 3.75B | 7.08 | -5.04 | - | ||
IE00B3NM2Q33 | 1.83B | 13.58 | 12.62 | 7.98 | ||
IE00BF0GL543 | 1.42B | 2.87 | 15.94 | - | ||
IE00BD81XT55 | 390.15M | 15.19 | 1.26 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review